Open AccessThe effectiveness of nab-paclitaxel plus gemcitabine and gemcitabine monotherapy in first-line metastatic pancreatic cancer treatment: A real-world evidence
Author(s) -
Juraj Prejac,
Dora Tomek Hamzić,
Nikša Librenjak,
Irma Goršić,
Domina Kekez,
Stjepko Pleština
Publication year - 2022
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000030566
Subject(s) - gemcitabine , medicine , oncology , pancreatic cancer , folfirinox , performance status , paclitaxel , retrospective cohort study , chemotherapy , cancer , irinotecan , colorectal cancer